GlobeNewswire
Capricor Therapeutics and Parent Project Muscular Dystrophy to Host Webinar Highlighting Positive Phase 3 HOPE-3 Topline Results in Duchenne Muscular Dystrophy
📈
AI Sentiment
Highly Positive
9/10
Capricor Therapeutics Inc. News
Latest updates and market news for CAPR
2 news
Dec 12 - Dec 18, 2025
Page 1
Share this news page